Stay updated with breaking news from Evolus Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evolus (NASDAQ:EOLS – Get Free Report) and Clever Leaves (NASDAQ:CLVR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Risk and Volatility Evolus has a beta of […]
HC Wainwright reissued their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. EOLS has been the subject of a number of other research reports. Barclays upgraded Evolus from an equal weight rating to an […]
Shares of Evolus, Inc. (NASDAQ:EOLS – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $13.76, but opened at $13.36. Evolus shares last traded at $13.58, with a volume of 12,338 shares traded. Wall Street Analysts Forecast Growth EOLS has been the subject of several research analyst […]
Shares of Evolus, Inc. (NASDAQ:EOLS – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $13.76, but opened at $13.36. Evolus shares last traded at $13.58, with a volume of 12,338 shares traded. Wall Street Analysts Forecast Growth EOLS has been the subject of several research analyst […]
Essex Investment Management Co. LLC reduced its position in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 1.3% in the 3rd quarter, Holdings Channel reports. The firm owned 274,804 shares of the company’s stock after selling 3,574 shares during the quarter. Essex Investment Management Co. LLC’s holdings in Evolus were worth $2,512,000 at the end of […]